Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report

The American Society of Clinical Oncology (ASCO) has named “refinement of the surgical treatment of cancer” as the 2020 Advance of the Year within the field of oncology clinic research. This announcement was made in “Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology,” which was published in the Journal of Clinical Oncology. “Therapeutic enhancements that contributed to improvements in surgical practice and timing, wrote ASCO’s President, Howard A. “Skip” Burris III, MD, FACP, FASCO, have specifically contributed to “less invasive approaches for advanced melanoma, reduced the need for surgery in renal cell carcinoma, and increased the number of patients with pancreatic cancer who can undergo surgery.”